Refractory inflammatory bowel disease-could it be an irritable bowel?

被引:3
作者
Meng, Jie [2 ]
Agrawal, Anurag [3 ]
Whorwell, Peter J. [1 ]
机构
[1] Wythenshawe Hosp, Educ & Res Ctr, Manchester M23 9LT, Lancs, England
[2] Beijing Univ Chinese Med, Dept Gastroenterol, Dongfang Hosp, Beijing 100078, Peoples R China
[3] Doncaster Royal Infirm, Dept Gastroenterol, Doncaster DN2 5LT, England
关键词
FUNCTIONAL GASTROINTESTINAL DISORDERS; QUALITY-OF-LIFE; IBS-LIKE SYMPTOMS; ULCERATIVE-COLITIS; INTESTINAL MICROBIOTA; REMISSION; DIAGNOSIS; MAINTENANCE; RIFAXIMIN; IMPACT;
D O I
10.1038/nrgastro.2012.173
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Patients with IBD who are apparently in remission-as indicated by normal blood tests, endoscopic findings and ultrasonography results-often continue to experience symptoms. Furthermore, despite these negative findings, there is a temptation to increase their anti-inflammatory medication in the hope that this approach would lead to some improvement. However, this strategy often seems to fail and can sometimes lead to adverse events. Consequently, when evidence of continuing inflammatory activity is lacking it might be appropriate to consider the possibility of co-existent IBS in these patients and to treat them for this condition. Dietary manipulation, antispasmodic agents, antidepressants (especially of the tricyclic variety) and even behavioural treatments might result in a worthwhile improvement of symptoms. Meng, J. et al. Nat. Rev. Gastroenterol. Hepatol. 10, 58-61 (2013); published online 11 September 2012; doi:10.1038/nrgastro.2012.173
引用
收藏
页码:58 / 61
页数:4
相关论文
共 51 条
[1]   Review article: abdominal bloating and distension in functional gastrointestinal disorders - epidemiology and exploration of possible mechanisms [J].
Agrawal, A. ;
Whorwell, P. J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (01) :2-10
[2]   Ulcerative colitis and irritable bowel syndrome: relationships with quality of life [J].
Ansari, Reza ;
Attari, Fatemeh ;
Razjouyan, Hadi ;
Etemadi, Arash ;
Amjadi, Hiva ;
Merat, Shahin ;
Malekzadeh, Reza .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (01) :46-50
[3]   Faecal calprotectin - a useful tool in the management of inflammatory bowel disease [J].
Burri, Emanuel ;
Beglinger, Christoph .
SWISS MEDICAL WEEKLY, 2012, 142
[4]   Managing symptoms of irritable bowel syndrome in patients with inflammatory bowel disease [J].
Camilleri, Michael .
GUT, 2011, 60 (04) :425-428
[5]   Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome [J].
Carroll, I. M. ;
Ringel-Kulka, T. ;
Siddle, J. P. ;
Ringel, Y. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 (06) :521-+
[6]   The Relationship Between Intestinal Microbiota and the Central Nervous System in Normal Gastrointestinal Function and Disease [J].
Collins, Stephen M. ;
Bercik, Premysl .
GASTROENTEROLOGY, 2009, 136 (06) :2003-2014
[7]   Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: Prevalence and impact on health [J].
Farrokhyar, F ;
Marshall, JK ;
Easterbrook, B ;
Irvine, EJ .
INFLAMMATORY BOWEL DISEASES, 2006, 12 (01) :38-46
[8]   Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis [J].
Ford, A. C. ;
Talley, N. J. ;
Schoenfeld, P. S. ;
Quigley, E. M. M. ;
Moayyedi, P. .
GUT, 2009, 58 (03) :367-378
[9]   BRAN AND IRRITABLE-BOWEL-SYNDROME - TIME FOR REAPPRAISAL [J].
FRANCIS, CY ;
WHORWELL, PJ .
LANCET, 1994, 344 (8914) :39-40
[10]   Effects of dietary fiber on inflammatory bowel disease [J].
Galvez, J ;
Rodríguez-Cabezas, ME ;
Zarzuelo, A .
MOLECULAR NUTRITION & FOOD RESEARCH, 2005, 49 (06) :601-608